Cogent is seeking a seasoned, dynamic individual with extensive commercial and analytics experience to join our growing Commercial organization. Reporting to the VP of Commercial Operations and Analytics, this role supports the success of Cogent’s portfolio through operational excellence and driving data-driven decision-making across the organization. In addition, this role will be key to champion initiatives to improve the effectiveness, profitability and growth of the commercial organization, whilst driving Cogent’s customer engagement transformation.
In the short term this role will play a pivotal role in driving Bezuclastinib to the commercial stage by providing and supporting commercial leadership in four key areas. The first is launch excellence: building the platform capabilities, metrics and reporting to assess launch readiness and flawless launches of all pipeline products. The second is marketing excellence: support the marketing organization by building data driven epidemiological forecasts and data to support their marketing plans. The third is sales excellence: planning for the eventual salesforce that will need the tools, training, data, insights and targets to accelerate customer engagement and product demand. The fourth is commercial operations: identifying and leading the key initiatives, projects and processes that will support the commercial operating plan and long-range forecast process for all products in Cogent’s pipeline. The role will collaborate with other stakeholders across the organization (e.g., Marketing, Medical, Pricing and Market Access, Market Development, and Sales) to ensure best practices, alignment and execution of priorities and processes.
This position will work out of the Waltham, Massachusetts office.
Cogent Biosciences is a biotechnology company developing real solutions to treat genetically driven diseases. With a focus on rational drug discovery and development, we are leveraging validated biology to advance precision therapies designed to a...
10 jobsSubscribe to Rise newsletter